Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscleinvasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette- Guérin (BCG): results of an international individual patient data survey (IPDS)

OBJECTIVES: To examine the management of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC), particularly with regard to the use of bacillus Calmette-Guérin (BCG) therapy, in North America and Europe. To compare NMIBC management practices to European Association of Urology (EAU)...

Descripción completa

Detalles Bibliográficos
Autores principales: Witjes, J Alfred, Palou, Joan, Soloway, Mark, Lamm, Donald, Kamat, Ashish M, Brausi, Maurizio, Persad, Raj, Buckley, Roger, Colombel, Marc, Böhle, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2013
Materias:
Urological Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933735/
https://www.ncbi.nlm.nih.gov/pubmed/23452187
http://dx.doi.org/10.1111/bju.12012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933735/
https://www.ncbi.nlm.nih.gov/pubmed/23452187
http://dx.doi.org/10.1111/bju.12012

Ejemplares similares